Celldex Therapeutics (CLDX) Total Debt (2010 - 2013)
Celldex Therapeutics (CLDX) posted quarterly Total Debt of $15.7 million for Q1 2013, up 3.6% year-over-year from $15.2 million in Q1 2012, and up 38.74% quarter-over-quarter from $11.3 million in Q4 2012.
Celldex Therapeutics (CLDX) Total Debt (2010 - 2013) Analysis & Trends
Celldex Therapeutics' Total Debt history runs 4 years deep, the most recent figure standing at $15.7 million for Q1 2013.
- In Q1 2013, Total Debt rose 3.6% year-over-year to $15.7 million; the TTM figure through Mar 2013 stood at $15.7 million (up 3.6% YoY), while the FY2012 annual figure was $11.3 million, down 25.13% from the prior year.
- Total Debt for Q1 2013 stood at $15.7 million, up from $11.3 million in the prior quarter.
- The five-year high for Total Debt was $19.2 million in Q2 2012, with the low at $10.0 million in Q4 2010.
- The 4-year median for Total Debt is $15.1 million (2011), against an average of $14.4 million.
- The sharpest annual moves came in 2011 and 2012: Total Debt soared 51.44% in 2011, then decreased 25.13% in 2012.
- Celldex Therapeutics' Total Debt stood at $10.0 million in 2010, then jumped by 51.44% to $15.1 million in 2011, then decreased by 25.13% to $11.3 million in 2012, then jumped by 38.74% to $15.7 million in 2013.
- Business Quant data shows CLDX's Total Debt at $15.7 million in Q1 2013, $11.3 million in Q4 2012, and $12.6 million in Q3 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 15.73 Mn |
| Dec 31, 2012 | 11.34 Mn |
| Sep 30, 2012 | 12.62 Mn |
| Jun 30, 2012 | 19.19 Mn |
| Mar 31, 2012 | 15.18 Mn |
| Dec 31, 2011 | 15.14 Mn |
| Sep 30, 2011 | 15.11 Mn |
| Jun 30, 2011 | 15.07 Mn |
| Mar 31, 2011 | 15.00 Mn |
| Dec 31, 2010 | 10.00 Mn |